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Background: Current indications for adrenalectomy include functional adrenal tumors and potentially
malignant tumors based on imaging studies. We evaluated the effectiveness of magnetic resonance
imaging (MRI) in obtaining a correct preoperative diagnosis.
Method: Fifty-three patients with nonfunctional adrenal lesions were analyzed. Indications for adre-
nalectomy of nonfunctional adrenal lesions included >6 cm in size and 6 cm in size with atypical
characteristics on MRI. Lesions with a size of >6 cm, local invasion, irregular margins, and chemical-shift
imaging that demonstrated no loss of signal intensity on out-of-phase images were considered suspected
of malignancy.
Results: Adrenal lesions of >6 cm in size exhibited an 80-fold increased prediction of malignancy
(OR: 80; 95% CI 7.8e813), whereas irregular margins and local invasion exhibited a 45-fold (OR: 45; 95%
CI 6.4e312.5) and a 12-fold (OR: 12; 95% CI 4.6e30.6) increased occurrence of malignancy, respectively.
The loss of signal intensity did not affect the prediction of malignancy.
Conclusion: The rate of unnecessary tumor resections that are <6 cm in size can be decreased by per-
forming adrenal biopsies in selected cases or by short-term follow-up to prevent the insufﬁciency of
imaging techniques.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Non-functioning adrenal lesions have become a common clin-
ical problem as a result of the more widespread use of high-
resolution anatomical imaging procedures.1e3 Incidental adrenal
masses are present in 4% of imaging studies in the general pop-
ulation, and the risk of ﬁnding an adrenal incidentaloma increases
with age.4e7 Most of these lesions are benign in nature. Typically,
the goals of an initial workup are to distinguish benign from
malignant processes and to distinguish nonfunctioning from
hyperfunctioning tumors.8e11
Chemical-shift imaging is most commonly used to distinguish
between benign and malignant adrenal lesions.12e15 Benign adrenal
masses typically demonstrate a loss of signal intensity on chemical-
shiftmagnetic resonance (MR) imagingusingopposed-phase images: þ90 2125341605.
ciates Ltd. Published by Elsevier Ltwith a 95% sensitivity.12e15 Although chemical-shift MR imaging is
a well-known predictor of malignancy, the indication for surgery in
surgical series is common in nonfunctioning adenomas.10,15e18
Current indications for adrenalectomy include functional
adrenal tumors and potentially malignant tumors based on the
results of imaging studies.3,5,17,18 Because MR ﬁnding are often
inconsistent with a diagnosis of adenoma, the majority of surgically
removed adrenal lesions are classiﬁed as benign nonfunctioning
adenomas. The aim of this work was to evaluate theeffectiveness
of combined CT parameters for distinguishing benignfrom malig-
nant adrenal masses.
2. Material and methods
2.1. Patients
We reviewed the data for 132 consecutive adrenalectomy patients from 2005
to 2012 at the Department of Surgery at the Istanbul Faculty of Medicine. After
excluding 58 patients with functional adenomas (27 patients with adrenal and
pituitary Cushing’s syndrome, 23 pheochromocytomas and 8 patients with Conn
syndrome), 13 patients with metastatic carcinoma, 3 patients with cortical carci-
noma and 6 patients with incomplete records, 53 consecutive patients withd. All rights reserved.
Table 1
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women and 14 men with a mean age of 44.1 years (range 23e76 years). The study
plan was reviewed and approved by the hospital’s institutional ethics committee.
2.2. Operation
Indications for adrenalectomy of nonfunctional adrenal masses were masses
that were >6 cm in size (29 patients, 15%) and 6 cm in size showing atypical
characteristics on MRI (28 patients, 15%). Adrenalectomy was performed by endo-
crine surgeons either laparoscopically or through open surgery. The patients who
manifested preoperative radiologic features of gross local invasion or systemic
metastases underwent open adrenalectomy.
2.3. Magnetic resonance imaging
Routine magnetic resonance imaging was used to predict benign or malignant
status and size of all adrenal masses. Chemical-shift imaging was performed using
a Tl-weighted gradient-recalled echo sequence. Masses that appeared hypo- or
isointense relative to the liver on T1-weighted images and hyper- or isointense to
the liver on T2-weighted images, as well as those that lost signal intensity on
opposed-phase images compared with in-phase images, were diagnosed as
adenomas. High signal intensity of homogenous adrenal masses on T2-weighted
images and no signal loss on opposed-phase images compared with in-phase
images were considered inconsistent with a diagnosis of benign adenoma.
The following MRI parameters were assessed in all adrenal masses: (i) size; (ii)
local invasion; (iii) irregularmargins; and (iv) chemical-shift imaging demonstrating
loss of signal intensity on out-of-phase images.
2.4. Evaluation of the diagnostic value
Lesions with a size >6 cm, local invasion, irregular margins, and chemical-shift
imaging demonstrating no loss of signal intensity on out-of-phase images were
suspected of malignancy. Suspicious imaging results and malignant pathology were
considered true positive (TP) for cases in which histological examination revealed
a malignancy, and the results were considered false positive (FP) when no malig-
nancy was found (including myelolipoma, ganglioneuroma, or Schwannoma). The
benign imaging results and benign pathology were considered true negative (TN) if
the histological ﬁndings were benign, and these results were considered false
negative (FN) for cases of histologically proven malignancy.
The sensitivity, speciﬁcity, diagnostic accuracy, positive predictive value (PPV)
and negative predictive value (NPV) of imaging and histopathologic results were
calculated. Sensitivity, speciﬁcity and accuracy were determined according to the
following formulas:
 PPV (%) ¼ TP/TP þ FP  100
 NPV (%) ¼ TN/TN þ FN  100
 Sensitivity (%) ¼ TP/TP þ FN  100
 Speciﬁcity (%) ¼ TN/TN þ FP  100
 Accuracy (%) ¼ TP þ TN/TP þ TN þ FP þ FN  100
2.5. Statistical analysis
The results were reported as the mean  SD and median. Statistical analyses
were performed with SPSS software (SPSS Inc., Chicago, IL). Differences between the
parameters were compared with the Mann Whitney U and the chi-square test.
Correlation analyses were performed using the non-parametric Spearman’s corre-
lation test. Chi-square analysis was used to evaluate the accuracy of MRI charac-
teristics with histopathologic correlations.MR imaging ﬁndings vs. ﬁnal pathology.
Size >6 cm _Irregular
margin
Local
invasion
No loss of
signal
intensity
TP (n) 9 8 5 8
TN (n) 44 44 44 9
FP (n) 0 0 0 35
FN (n) 0 1 4 1
PPV (%) 100 100 100 18
NPV (%) 100 97 91 90
Sensitivity (%) 100 88 55 88
Speciﬁcity (%) 100 100 100 20
Diagnostic
accuracy (%)
100 98 92 32
TP, true positive; FP, false positive; TN, true negative; FN, false negative; PPV,
positive predictive value; NPV, negative predictive value.3. Results
The mean adrenal lesion size was 6.6 5.2 cm (range 3e30 cm).
Open adrenalectomywas required in 5 patients due to the large size
of the lesion or invasion of the adjacent organs on preoperative
imaging. Laparoscopic adrenalectomies were performed in 48
patients; all procedures were performed using a lateral trans-
abdominal approach. None of the laparoscopic adrenalectomies
were converted to an open approach.
Histopathological evaluation revealed a benign pathology in
44 (83%) adrenal lesion (38 adenoma, 2 infarcted necrosis, 3
Schwannoma, and 1 myelolipoma) and a malignant pathology in
9 (17%) adrenal lesions (6 adrenal cortex carcinoma and 1
liposarcoma).3.1. MRI results
Of the 53 adrenal lesions, 9 (16.9%) lesions were more than 6 cm
in size, 8 (15.1%) lesions exhibited irregular margins, and 5 (9.4%)
lesions exhibited local invasion. All of these lesions exhibited
a malignant pathology. Forty-three lesions (81.1%) exhibited no loss
of signal intensity. Of the 43 adrenal lesions with no loss of signal
intensity, 8 (18.6%) lesions exhibited a malignant pathology, but 35
(81.4%) lesions exhibited a benign pathology.
3.2. MR imaging ﬁndings vs. ﬁnal pathology
Based on the MR imaging ﬁndings, size correctly diagnosed
(true positive and true negative) 53 adrenal lesions and failed to
diagnose 0 lesions. Irregular margins correctly diagnosed 52
adrenal lesions and failed to diagnose 1 lesion. Local invasion
correctly diagnosed 49 adrenal lesions and failed to diagnose 4
lesions. Loss of signal intensity on out-of-phase images correctly
diagnosed 17 adrenal lesions and failed to diagnose 36 lesions.
The sensitivity of size, irregular margins, local invasion, and no
loss of signal intensity in predicting malignancy was 100%, 88%, 55%
and 88%, respectively. The speciﬁcity of size, irregular margins, local
invasion, and no loss of signal intensity in predicting malignancy
was 100%, 100%, 100% and 20%, respectively. The diagnostic accu-
racy of size, irregular margins, local invasion, and loss of signal
intensity in predicting malignancy was 100%, 98%, 92% and 32%,
respectively (Table 1).
3.3. The evaluation of the adrenal lesions according to the ﬁnal
pathology
The adrenal lesions were divided into 2 groups according to the
ﬁnal pathology. Group I (n¼ 9) consisted of malignant pathologies;
group 2 (n ¼ 44) consisted of benign pathologies. The mean size
(16.4  6.5 cm), the ratio of irregular margins (88.9%), and the ratio
of local invasion (55.6%) in group 1 was signiﬁcantly higher than
that of group 2 (4.6  1 cm, 0%, and 0%) (p < 0.001). The ratio of no
loss of signal intensity did not signiﬁcantly differ between groups 1
and 2 (88.9% and 79.5%) (Table 2).
3.4. Correlations
There was a positive correlation between the malignant
pathology and size (r ¼ 0.653, p ¼ 0.0001), irregular margins
(r ¼ 0.932, p ¼ 0.0001) and local invasion (r ¼ 0.714, p ¼ 0.0001).
The malignant pathology did not correlate with the loss of signal
intensity (r ¼ 0.090, p ¼ 0.523) (Table 3).
Table 2
The evaluation of the adrenal lesions according to the ﬁnal pathology.
Group 1 (n ¼ 9) Group 2 (n ¼ 44) p
Size (cm) 16.4  6.5 4.6  1 0.001
_Irregular margin (n; %) 8; 88.9 0; 0 0.001
Local invasion (n; %) 5; 55.6 0; 0 0.001
No loss of signal intensity
(n; %)
8; 88.9 35; 79.5 NS
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An adrenal lesion size greater than 6 cm had an 80-fold (OR: 80;
95% CI 7.8e813) increased prediction of malignancy, whereas
irregular margins and local invasion exhibited a 45-fold (OR: 45;
95% CI 6.4e312.5) and a 12-fold (OR: 12; 95% CI 4.6e30.6) increased
prediction of malignancy, respectively. The loss of signal intensity
did not affect the prediction of malignancy.
4. Discussion
We investigated the accuracy of MR imaging features for dis-
tinguishing malignant from benign adrenal lesions. We found that
the most helpful diagnostic MR imaging features included tumor
size, irregular margins, and local invasion. Adrenal lesion size was
found to be a better diagnostic parameter than other features.
Chemical-shift imaging was not useful in distinguishing malignant
from benign adrenal lesions.
With improving quality and wider availability of imaging tech-
niques, incidental detection of adrenal masses is an increasing
trend. Incidental discoveries of adrenal masses are observed in 4%e
10% of patients undergoing imaging. Most of these lesions are found
to be benign and nonfunctioning adenomas.1e4
In the management of adrenal incidentalomas, two issues must
be discussed thoroughly: the lesion’s malignancy and its func-
tionality. The two major predictors of malignancy are the tumor’s
size and the features observed during imaging.8,9 The larger the
mass, the more likely it is to be malignant. Adrenocortical carci-
nomas represent 2% of all tumors that are 4 cm or less in diameter,
6% of tumors ranging from 4.1 to 6 cm, and 25% of tumors that are
larger than 6 cm.4,16,19
Although tumor size is a well-known predictor of malignancy, it
is not the best indicator of malignancy. The NIH consensus state-
ment emphasized removing an adrenal tumor if there is a suspicion
of malignancy based on imaging ﬁndings, regardless of tumor
size.19
CT and MR imaging have been the principal imaging techniques
for observing adrenal glands for many years. More recently,
chemical-shift MR imaging has been widely used to distinguish
between benign and malignant tumors. Several studies revealed
that chemical-shift imaging MR exhibits a diagnostic accuracy of
96%e100%.7,12e15 However, the diagnostic accuracy of chemical-
shift MR was only 32% in our study. Thirty-ﬁve benign adenomas
(79.5%) could not be differentiated from adenomatous lesions using
this technique due to their failure to exhibit signal loss on out-of-
phase images.
We observed a difference in the chemical-shift MR results
between our study and the radiology series in the literature.Table 3
Correlations.
r p
Malignite Size 0.653 0.0001
_Irregular margin 0.932 0.0001
Local invasion 0.714 0.0001In surgical series such as our study, approximately 50% of the
lesions removed for surgical indications were nonfunctional
adenomas,10,15e18 whereas nonfunctional adenomas account for 10%
of lesions removed in radiology studies.12e15 Due to the uncertain
results of imaging studies, most of the lesions smaller than 6 cm are
resected, resulting in benign pathologies after histological exami-
nation. The operative indications for these lesions are the result of
imaging studies.
Conzo et al.10 reported that out of 114 nonfunctional adenomas
smaller than 6 cm that were resected due to the imaging results,
only one malignant pathology was observed. In another study of
196 adrenalectomies, a total of 61 (31%) adenomas were identiﬁed,
all with benign pathologies.15 We believe that if imaging studies
were able to correctly diagnose lesions during the preoperative
evaluation, surgeons would be able to prevent needless surgical
resections in these studies.
Although the indications for adrenalectomy have not changed,
a large number of small incidentalomas have been removed in the
past few years.3,11,16 In our opinion, the large number of inci-
dentalomas is the result of indecisive identiﬁcation based on
imaging results.
In our study, 35 nonfunctional adenomas with suspicious MR
imaging results exhibited benign pathologies. Discordance
between imaging modalities occurred in 35 adrenal lesions.
Adrenal lesions with imaging characteristics that were inconsistent
with adenoma were commonly benign and lipid-poor adenomas,
resulting in the needless resection of approximately 66% of benign
nonfunctional adrenal lesions.
Although chemical-shift imaging has been the most popular
technique for predicting the malignancy of adrenal lesions, it may
exhibit limitations in particular situations, especially in cases of
lipid-poor adenomas. CT or MR imaging, adrenal biopsy, surgical
resection and clinical follow-up have been widely used to distin-
guish between benign and malignant tumors.3e5 The adrenal
biopsy of the adrenal glands is recommended in patients with
a known history of malignancy who are suspected to have adrenal
metastases.4,8
In conclusion, we believe that the rate of unnecessary resections
for tumors that are less than 6 cm in size can be decreased by
performing adrenal biopsies in selected cases or by short-term
follow-up to prevent the inconclusiveness of imaging techniques.
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